Velabs Therapeutics
Paul Sauter is currently the Director Chemistry & Bioconjugation at VERAXA Biotech GmbH since January 2020. Prior to this role, they were the Head Of Chemistry at EMBL from May 2016 to December 2019. Paul Sauter obtained their Ph.D. in Organic Chemistry from Karlsruhe Institute of Technology (KIT) in March 2016.
This person is not in any teams
Velabs Therapeutics
Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies.